Condition: Liver Retraction During Bariatric Surgery · Sponsor: Boehringer Labs LLC
This study aims to assess the safety and efficacy of an organ retraction device. The study is low risk as it is only being used in patients already undergoing primary robotic bariatric surgery.
This description comes directly from the study's public registry record.
Business Development · 4849312338 · elagunilla@boehringerlabs.com
Always discuss trial participation with your own doctor first.
| WakeMed Health & Hospitals | Raleigh, North Carolina, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06754514